Biosensors Products Quadrant Report

Table of Contents

1 Introduction
   1.1 Market Definition

2 Market Overview
   2.1 Introduction
   2.2 Market Dynamics
          Figure 1 Increasing Use of Biosensors to Monitor Diabetic Individuals and Growing Demand for Home-Based PoC Devices to Fuel the Growth of the Biosensors Market
          2.2.1 Drivers
                    2.2.1.1 Emergence of Nanotechnology-Based Biosensors
                    2.2.1.2 Significant Technological Advancements in Last Few Years
                    2.2.1.3 Increasing Use of Biosensors to Monitor Glucose Levels in Individuals With Diabetes
                    2.2.1.4 Increased Demand for Home-Based PoC Devices
                    2.2.1.5 Government Initiatives Toward Diagnostics
          2.2.2 Restraints
                    2.2.2.1 Slow Rate of Commercialization
                    2.2.2.2 High Cost Involved in R&D
                    2.2.2.3 Reluctance Toward Adoption of New Treatment Practices
          2.2.3 Opportunities
                    2.2.3.1 Emerging Market in Developing Countries
                    2.2.3.2 High-Growth Opportunities in Food Industry, Environmental Monitoring, and Biodefense
          2.2.4 Challenges
                    2.2.4.1 Government Regulations—Long Certification and Approval Cycles
                                  Table 1 Country-Based Policy, Standards, and Guidelines
                    2.2.4.2 Pricing Pressure in PoC Market

3 Company Evaluation Quadrant
   3.1 Visionary Leaders
   3.2 Dynamic Differentiators
   3.3 Innovators
   3.4 Emerging Companies
          Figure 2 Company Evaluation Quadrant (Global) Biosensors Market
   3.5 Strength of Product Portfolio
   3.6 Business Strategy Excellence

4 Competitive Landscape
   4.1 Overview
   4.2 Competitive Situations and Trends
         4.2.1 Product Launches
                   Table 2 Product Launch (2016–2018)
         4.2.2 Joint Ventures, Partnerships, and Collaborations
                   Table 3 Joint Venture, Partnership, and Collaboration (2016–2018)
         4.2.3 Acquisitions, Agreements, and Expansions
                   Table 4 Acquisition, Agreement, and Expansion (2015–2018)

5 Company Profiles
   5.1 Introduction
   5.2 Key Players
         5.2.1 Abbott Laboratories Inc.
                  5.2.1.1 Business Overview*
                                Figure 3 Abbott Laboratories, Inc.: Company Snapshot
                  5.2.1.2 Products Offered*
                  5.2.1.3 Recent Developments*
         5.2.1.4 SWOT Analysis*
         5.2.1.5 MnM View*
         (*Above sections are present for all of below companies)
         5.2.2 F. Hoffman-La Roche
                   Figure 4 F. Hoffman-La Roche: Company Snapshot
         5.2.3 Medtronic
                   Figure 5 Medtronic: Company Snapshot
         5.2.4 Universal Biosensors
                   Figure 6 Universal Biosensors: Company Snapshot
         5.2.5 Siemens
                   Figure 7 Siemens AG: Company Snapshot
         5.2.6 LifeScan
         5.2.7 Bayer Healthcare AG
                   Figure 8 Bayer Healthcare AG: Company Snapshot
         5.2.8 Bio-Rad Laboratories, Inc.
                   Figure 9 Bio-Rad Laboratories: Company Snapshot
         5.2.9 DowDuPont Inc.
                   Figure 10 DowDuPont Inc.: Company Snapshot
         5.2.10 Sysmex Corporation
                     Figure 11 Sysmex Corporation: Company Snapshot
         5.2.11 Biacore
         5.2.12 Biosensors International Pte. Ltd.
         5.2.13 Ercon Inc.
         5.2.14 LifeSensors
         5.2.15 Nova Biomedical
         5.2.16 ACON Laboratories, Inc.
         5.2.17 Pharmaco-Kinesis Corporation

6 Appendix
   6.1 Other Significant Players
         6.1.1 NeuroSky, Inc.
         6.1.2 Graphene Frontiers
         6.1.3 HMicro Inc.
         6.1.4 Xsensio SA
         6.1.5 Innovative Sensor Technology IST AG
         6.1.6 Eastprint Incorporated
         6.1.7 Pinnacle Technology
         6.1.8 OxiRate
   6.2 Methodology

Abbott Point of Care Inc. (US), Medtronic Inc. (US), LifeScan Inc. (US), Universal Biosensors Inc. (Australia), F. Hoffman-La Roche Ltd. (Switzerland) are some of the best Biosensor manufacturers in the global Biosensors market. 

This report identifies and benchmarks key players in the Biosensors Market and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Biosensors ecosystem combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on a 2x2 matrix, called as ‘Company Evaluation Quadrant,’ and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies.

SAMPLES: